TreeWAS – Variant ID: rs10447393

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	1.000	0.000	0.000
E83.1 Disorders of iron metabolism	0.000	0.000	1.000
E05 Thyrotoxicosis [hyperthyroidism]	1.000	0.000	0.000
E10 Insulin-dependent diabetes mellitus	1.000	0.000	0.000
E05.9 Thyrotoxicosis, unspecified	1.000	0.000	0.000
E10-E14 Diabetes mellitus	0.999	0.001	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.999	0.001	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.998	0.002	0.000
E16 Other disorders of pancreatic internal secretion	0.998	0.002	0.000
E00-E07 Disorders of thyroid gland	0.998	0.002	0.000
E16.2 Hypoglycaemia, unspecified	0.997	0.003	0.000
E10.9 Without complications	0.997	0.003	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.994	0.006	0.000
R31 Unspecified haematuria	0.000	0.013	0.987
E10.4 With neurological complications	0.948	0.052	0.000
E10.2 With renal complications	0.925	0.075	0.000
E10.3 With ophthalmic complications	0.870	0.130	0.000
E10.1 With ketoacidosis	0.867	0.133	0.000
E16.1 Other hypoglycaemia	0.841	0.159	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.840	0.160	0.000
E10.5 With peripheral circulatory complications	0.809	0.191	0.000
E40-E46 Malnutrition	0.806	0.194	0.000
E05.8 Other thyrotoxicosis	0.800	0.200	0.000
E14 Unspecified diabetes mellitus	0.789	0.211	0.000
E10.6 With other specified complications	0.785	0.215	0.000
E10.0 With coma	0.784	0.216	0.000
E07 Other disorders of thyroid	0.766	0.234	0.000
E13 Other specified diabetes mellitus	0.754	0.246	0.000
E10.7 With multiple complications	0.743	0.257	0.000
E05.5 Thyroid crisis or storm	0.717	0.283	0.000
E05.4 Thyrotoxicosis factitia	0.717	0.283	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.717	0.283	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.717	0.283	0.000
E12 Malnutrition-related diabetes mellitus	0.716	0.284	0.000
E15 Nondiabetic hypoglycaemic coma	0.716	0.284	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.716	0.284	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.716	0.284	0.000
E16.4 Abnormal secretion of gastrin	0.716	0.284	0.000
E16.3 Increased secretion of glucagon	0.716	0.284	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.715	0.285	0.000
E00 Congenital iodine-deficiency syndrome	0.715	0.285	0.000
E07.8 Other specified disorders of thyroid	0.703	0.297	0.000
E46 Unspecified protein-energy malnutrition	0.668	0.332	0.000
E14.4 With neurological complications	0.662	0.338	0.000
E14.3 With ophthalmic complications	0.655	0.345	0.000
E20-E35 Disorders of other endocrine glands	0.616	0.384	0.000
E14.8 With unspecified complications	0.607	0.393	0.000
E14.1 With ketoacidosis	0.603	0.397	0.000
E14.5 With peripheral circulatory complications	0.592	0.408	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.578	0.422	0.000
E45 Retarded development following protein-energy malnutrition	0.578	0.422	0.000
E43 Unspecified severe protein-energy malnutrition	0.578	0.422	0.000
E42 Marasmic kwashiorkor	0.578	0.422	0.000
E41 Nutritional marasmus	0.578	0.422	0.000
E40 Kwashiorkor	0.578	0.422	0.000
E14.6 With other specified complications	0.570	0.430	0.000
E14.7 With multiple complications	0.565	0.434	0.000
E14.0 With coma	0.565	0.434	0.000
E13.3 With ophthalmic complications	0.563	0.436	0.000
E50-E64 Other nutritional deficiencies	0.563	0.437	0.000
E13.9 Without complications	0.557	0.443	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.555	0.444	0.000
E07.1 Dyshormogenetic goitre	0.549	0.451	0.000
E07.0 Hypersecretion of calcitonin	0.549	0.451	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.544	0.456	0.000
E14.2 Withrenal complications	0.541	0.459	0.000
E13.8 With unspecified complications	0.540	0.459	0.000
E13.7 With multiple complications	0.540	0.459	0.000
E13.6 With other specified complications	0.540	0.459	0.000
E13.5 With peripheral circulatory complications	0.540	0.459	0.000
E13.4 With neurological complications	0.540	0.459	0.000
E13.2 With renal complications	0.540	0.459	0.000
E13.1 With ketoacidosis	0.540	0.459	0.000
E13.0 With coma	0.540	0.459	0.000
E28 Ovarian dysfunction	0.538	0.462	0.000
E24 Cushing's syndrome	0.519	0.481	0.000
E12.9 Without complications	0.514	0.486	0.000
E12.8 With unspecified complications	0.514	0.486	0.000
E12.7 With multiple complications	0.514	0.486	0.000
E12.6 With other specified complications	0.514	0.486	0.000
E12.5 With peripheral circulatory complications	0.514	0.486	0.000
E12.4 With neurological complications	0.514	0.486	0.000
E12.3 With ophthalmic complications	0.514	0.486	0.000
E12.2 With renal complications	0.514	0.486	0.000
E12.1 With ketoacidosis	0.514	0.486	0.000
E12.0 With coma	0.514	0.486	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.513	0.487	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.513	0.487	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.513	0.487	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.513	0.487	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.513	0.487	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.513	0.487	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.513	0.487	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.513	0.487	0.000
E34 Other endocrine disorders	0.506	0.494	0.000
E06 Thyroiditis	0.500	0.500	0.000
E10.8 With unspecified complications	0.483	0.516	0.001
E32 Diseases of thymus	0.481	0.519	0.000
E28.2 Polycystic ovarian syndrome	0.475	0.525	0.000
E20 Hypoparathyroidism	0.474	0.526	0.000
E54 Ascorbic acid deficiency	0.458	0.541	0.000
E29 Testicular dysfunction	0.458	0.542	0.000
E25 Adrenogenital disorders	0.450	0.550	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.442	0.558	0.000
E30 Disorders of puberty, not elsewhere classified	0.442	0.558	0.000
E31 Polyglandular dysfunction	0.440	0.560	0.000
E34.9 Endocrine disorder, unspecified	0.435	0.565	0.000
E24.2 Drug-induced Cushing's syndrome	0.427	0.572	0.000
E61 Deficiency of other nutrient elements	0.425	0.575	0.000
E44.1 Mild protein-energy malnutrition	0.414	0.585	0.000
E44.0 Moderate protein-energy malnutrition	0.414	0.585	0.000
E24.0 Pituitary-dependent Cushing's disease	0.410	0.590	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.404	0.596	0.000
E63 Other nutritional deficiencies	0.404	0.596	0.000
E50 Vitamin A deficiency	0.404	0.596	0.000
E60 Dietary zinc deficiency	0.404	0.596	0.000
E59 Dietary selenium deficiency	0.404	0.596	0.000
E52 Niacin deficiency [pellagra]	0.404	0.596	0.000
E34.8 Other specified endocrine disorders	0.404	0.596	0.000
E51 Thiamine deficiency	0.401	0.599	0.000
E28.3 Primary ovarian failure	0.401	0.599	0.000
E83 Disorders of mineral metabolism	0.004	0.600	0.395
E56 Other vitamin deficiencies	0.396	0.604	0.000
E03 Other hypothyroidism	0.394	0.606	0.000
E06.9 Thyroiditis, unspecified	0.390	0.610	0.000
E28.9 Ovarian dysfunction, unspecified	0.386	0.614	0.000
E28.8 Other ovarian dysfunction	0.386	0.614	0.000
E28.1 Androgen excess	0.386	0.614	0.000
E28.0 Oestrogen excess	0.386	0.614	0.000
E32.9 Disease of thymus, unspecified	0.385	0.615	0.000
E22 Hyperfunction of pituitary gland	0.376	0.624	0.000
E24.9 Cushing's syndrome, unspecified	0.375	0.625	0.000
E83.3 Disorders of phosphorus metabolism	0.001	0.627	0.373
E23 Hypofunction and other disorders of pituitary gland	0.373	0.627	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.372	0.628	0.000
E24.3 Ectopic ACTH syndrome	0.372	0.628	0.000
E24.1 Nelson's syndrome	0.372	0.628	0.000
E20.9 Hypoparathyroidism, unspecified	0.372	0.628	0.000
E24.8 Other Cushing's syndrome	0.366	0.634	0.000
E34.5 Androgen resistance syndrome	0.363	0.637	0.000
E34.4 Constitutional tall stature	0.363	0.637	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.363	0.637	0.000
E34.1 Other hypersecretion of intestinal hormones	0.363	0.637	0.000
L40.9 Psoriasis, unspecified	0.361	0.639	0.000
E61.1 Iron deficiency	0.360	0.640	0.000
E06.4 Drug-induced thyroiditis	0.359	0.641	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.359	0.641	0.000
E06.1 Subacute thyroiditis	0.359	0.641	0.000
E06.0 Acute thyroiditis	0.359	0.641	0.000
E34.3 Short stature, not elsewhere classified	0.357	0.643	0.000
L40 Psoriasis	0.356	0.644	0.000
K90 Intestinal malabsorption	0.353	0.647	0.000
L40.5 Arthropathic psoriasis	0.348	0.652	0.000
E58 Dietary calcium deficiency	0.347	0.652	0.000
E32.8 Other diseases of thymus	0.345	0.655	0.000
E32.1 Abscess of thymus	0.345	0.655	0.000
E32.0 Persistent hyperplasia of thymus	0.345	0.655	0.000
E29.1 Testicular hypofunction	0.340	0.660	0.000
E20.8 Other hypoparathyroidism	0.340	0.660	0.000
E20.1 Pseudohypoparathyroidism	0.340	0.660	0.000
E20.0 Idiopathic hypoparathyroidism	0.340	0.660	0.000
E55 Vitamin D deficiency	0.334	0.666	0.000
E06.5 Other chronic thyroiditis	0.334	0.666	0.000
E29.9 Testicular dysfunction, unspecified	0.333	0.666	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.331	0.669	0.000
E29.8 Other testicular dysfunction	0.328	0.671	0.000
E29.0 Testicular hyperfunction	0.328	0.671	0.000
E26 Hyperaldosteronism	0.323	0.677	0.001
L40.0 Psoriasis vulgaris	0.323	0.677	0.000
E25.9 Adrenogenital disorder, unspecified	0.323	0.677	0.000
E25.8 Other adrenogenital disorders	0.323	0.677	0.000
E30.9 Disorder of puberty, unspecified	0.317	0.683	0.000
E30.8 Other disorders of puberty	0.317	0.683	0.000
E30.1 Precocious puberty	0.317	0.683	0.000
E30.0 Delayed puberty	0.317	0.683	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.317	0.683	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.317	0.683	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.317	0.683	0.000
E31.9 Polyglandular dysfunction, unspecified	0.316	0.684	0.000
E31.8 Other polyglandular dysfunction	0.316	0.684	0.000
E31.1 Polyglandular hyperfunction	0.316	0.684	0.000
E31.0 Autoimmune polyglandular failure	0.314	0.686	0.000
E23.7 Disorder of pituitary gland, unspecified	0.314	0.686	0.000
E22.1 Hyperprolactinaemia	0.308	0.692	0.000
E61.9 Deficiency of nutrient element, unspecified	0.305	0.695	0.000
E61.8 Deficiency of other specified nutrient elements	0.305	0.695	0.000
E61.7 Deficiency of multiple nutrient elements	0.305	0.695	0.000
E61.6 Vanadium deficiency	0.305	0.695	0.000
E61.5 Molybdenum deficiency	0.305	0.695	0.000
E61.4 Chromium deficiency	0.305	0.695	0.000
E61.3 Manganese deficiency	0.305	0.695	0.000
E61.0 Copper deficiency	0.305	0.695	0.000
E03.1 Congenital hypothyroidism without goitre	0.298	0.702	0.000
E53 Deficiency of other B group vitamins	0.297	0.703	0.000
E65-E68 Obesity and other hyperalimentation	0.295	0.705	0.000
E34.0 Carcinoid syndrome	0.294	0.705	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.293	0.707	0.000
E50.9 Vitamin A deficiency, unspecified	0.289	0.710	0.000
E50.8 Other manifestations of vitamin A deficiency	0.289	0.710	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.289	0.710	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.289	0.710	0.000
E50.5 Vitamin A deficiency with night blindness	0.289	0.710	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.289	0.710	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.289	0.710	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.289	0.710	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.289	0.710	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.289	0.710	0.000
E63.9 Nutritional deficiency, unspecified	0.289	0.710	0.000
E63.8 Other specified nutritional deficiencies	0.289	0.710	0.000
E63.1 Imbalance of constituents of food intake	0.289	0.710	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.289	0.710	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.289	0.710	0.000
E64.8 Sequelae of other nutritional deficiencies	0.289	0.710	0.000
E64.3 Sequelae of rickets	0.289	0.710	0.000
E64.2 Sequelae of vitamin C deficiency	0.289	0.710	0.000
E64.1 Sequelae of vitamin A deficiency	0.289	0.710	0.000
E64.0 Sequelae of protein-energy malnutrition	0.289	0.710	0.000
E51.9 Thiamine deficiency, unspecified	0.288	0.712	0.000
E51.8 Other manifestations of thiamine deficiency	0.288	0.712	0.000
E51.1 Beriberi	0.288	0.712	0.000
E83.8 Other disorders of mineral metabolism	0.003	0.713	0.283
E83.2 Disorders of zinc metabolism	0.003	0.713	0.283
E83.0 Disorders of copper metabolism	0.003	0.713	0.283
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.286	0.714	0.000
E51.2 Wernicke's encephalopathy	0.285	0.715	0.000
E56.9 Vitamin deficiency, unspecified	0.284	0.716	0.000
E56.8 Deficiency of other vitamins	0.284	0.716	0.000
E56.0 Deficiency of vitamin E	0.284	0.716	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.003	0.717	0.279
E03.5 Myxoedema coma	0.282	0.717	0.000
E03.4 Atrophy of thyroid (acquired)	0.282	0.717	0.000
E03.3 Postinfectious hypothyroidism	0.282	0.717	0.000
L40.3 Pustulosis palmaris et plantaris	0.279	0.721	0.000
L40.1 Generalised pustular psoriasis	0.277	0.723	0.000
L40.4 Guttate psoriasis	0.277	0.723	0.000
E56.1 Deficiency of vitamin K	0.276	0.724	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.271	0.729	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.270	0.730	0.000
E22.8 Other hyperfunction of pituitary gland	0.270	0.730	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.268	0.732	0.000
E23.1 Drug-induced hypopituitarism	0.268	0.732	0.000
L40.2 Acrodermatitis continua	0.256	0.744	0.000
K90.3 Pancreatic steatorrhoea	0.253	0.747	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.253	0.747	0.000
K90.1 Tropical sprue	0.253	0.747	0.000
K90.8 Other intestinal malabsorption	0.250	0.750	0.000
E03.8 Other specified hypothyroidism	0.250	0.750	0.000
E23.6 Other disorders of pituitary gland	0.248	0.752	0.000
E11 Non-insulin-dependent diabetes mellitus	0.247	0.753	0.000
E61.2 Magnesium deficiency	0.244	0.756	0.000
E55.0 Rickets, active	0.240	0.760	0.000
E26.9 Hyperaldosteronism, unspecified	0.231	0.768	0.001
E26.8 Other hyperaldosteronism	0.231	0.768	0.001
E26.1 Secondary hyperaldosteronism	0.231	0.768	0.001
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.230	0.770	0.000
E27 Other disorders of adrenal gland	0.224	0.776	0.000
E23.0 Hypopituitarism	0.214	0.786	0.000
E11.1 With ketoacidosis	0.213	0.786	0.000
E53.1 Pyridoxine deficiency	0.213	0.787	0.000
E53.0 Riboflavin deficiency	0.213	0.787	0.000
E67 Other hyperalimentation	0.212	0.788	0.000
E68 Sequelae of hyperalimentation	0.212	0.788	0.000
E23.2 Diabetes insipidus	0.202	0.798	0.000
E27.1 Primary adrenocortical insufficiency	0.200	0.800	0.000
E11.6 With other specified complications	0.200	0.800	0.000
E07.9 Disorder of thyroid, unspecified	0.195	0.804	0.000
E11.5 With peripheral circulatory complications	0.194	0.806	0.000
E11.7 With multiple complications	0.193	0.807	0.000
L40.8 Other psoriasis	0.188	0.812	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.182	0.818	0.000
E53.9 Vitamin B deficiency, unspecified	0.182	0.818	0.000
E22.0 Acromegaly and pituitary gigantism	0.180	0.820	0.000
E83.4 Disorders of magnesium metabolism	0.002	0.821	0.178
E55.9 Vitamin D deficiency, unspecified	0.170	0.830	0.000
L40-L45 Papulosquamous disorders	0.169	0.831	0.000
E11.0 With coma	0.167	0.833	0.000
E27.5 Adrenomedullary hyperfunction	0.160	0.839	0.000
E27.0 Other adrenocortical overactivity	0.160	0.839	0.000
E53.8 Deficiency of other specified B group vitamins	0.158	0.842	0.000
E67.8 Other specified hyperalimentation	0.152	0.848	0.000
E67.3 Hypervitaminosis D	0.152	0.848	0.000
E67.2 Megavitamin-B6 syndrome	0.152	0.848	0.000
E67.1 Hypercarotenaemia	0.152	0.848	0.000
E67.0 Hypervitaminosis A	0.152	0.848	0.000
K90.9 Intestinal malabsorption, unspecified	0.150	0.850	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.140	0.860	0.000
E21.4 Other specified disorders of parathyroid gland	0.140	0.860	0.000
E65 Localised adiposity	0.139	0.860	0.000
L43 Lichen planus	0.138	0.861	0.000
E11.2 With renal complications	0.136	0.864	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.134	0.866	0.000
E27.2 Addisonian crisis	0.128	0.871	0.000
L43.9 Lichen planus, unspecified	0.127	0.873	0.000
L44 Other papulosquamous disorders	0.126	0.874	0.000
E11.8 With unspecified complications	0.126	0.874	0.000
L41 Parapsoriasis	0.121	0.879	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.121	0.879	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.117	0.883	0.000
E21.2 Other hyperparathyroidism	0.115	0.885	0.000
E26.0 Primary hyperaldosteronism	0.112	0.886	0.001
E27.9 Disorder of adrenal gland, unspecified	0.113	0.886	0.000
E21.3 Hyperparathyroidism, unspecified	0.113	0.887	0.000
E06.3 Autoimmune thyroiditis	0.112	0.887	0.001
E11.4 With neurological complications	0.111	0.889	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.110	0.890	0.000
E70-E90 Metabolic disorders	0.106	0.892	0.002
E14.9 Without complications	0.102	0.898	0.000
L42 Pityriasis rosea	0.102	0.898	0.000
L43.3 Subacute (active) lichen planus	0.099	0.900	0.000
L43.2 Lichenoid drug reaction	0.099	0.900	0.000
L43.1 Bullous lichen planus	0.099	0.900	0.000
L43.0 Hypertrophic lichen planus	0.099	0.900	0.000
L44.0 Pityriasis rubra pilaris	0.096	0.904	0.000
E85 Amyloidosis	0.091	0.908	0.001
L44.9 Papulosquamous disorder, unspecified	0.091	0.909	0.000
L44.8 Other specified papulosquamous disorders	0.091	0.909	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.091	0.909	0.000
L44.3 Lichen ruber moniliformis	0.091	0.909	0.000
L44.2 Lichen striatus	0.091	0.909	0.000
L44.1 Lichen nitidus	0.091	0.909	0.000
E74 Other disorders of carbohydrate metabolism	0.090	0.909	0.001
W22.9 Unspecified place	0.090	0.910	0.000
L41.9 Parapsoriasis, unspecified	0.087	0.913	0.000
L41.8 Other parapsoriasis	0.087	0.913	0.000
L41.5 Retiform parapsoriasis	0.087	0.913	0.000
L41.4 Large plaque parapsoriasis	0.087	0.913	0.000
L41.3 Small plaque parapsoriasis	0.087	0.913	0.000
L41.2 Lymphomatoid papulosis	0.087	0.913	0.000
L41.1 Pityriasis lichenoides chronica	0.087	0.913	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.087	0.913	0.000
E73 Lactose intolerance	0.084	0.915	0.001
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.082	0.917	0.001
W22 Striking against or struck by other objects	0.083	0.917	0.000
E85.4 Organ-limited amyloidosis	0.080	0.920	0.000
E11.3 With ophthalmic complications	0.080	0.920	0.000
E84 Cystic fibrosis	0.078	0.921	0.002
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.079	0.921	0.000
E72 Other disorders of amino-acid metabolism	0.077	0.921	0.002
E77 Disorders of glycoprotein metabolism	0.076	0.922	0.002
E76 Disorders of glycosaminoglycan metabolism	0.076	0.922	0.002
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.076	0.922	0.002
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.076	0.922	0.002
E78.2 Mixed hyperlipidaemia	0.077	0.923	0.000
E88 Other metabolic disorders	0.075	0.924	0.001
E70 Disorders of aromatic amino-acid metabolism	0.074	0.925	0.002
E74.0 Glycogen storage disease	0.073	0.926	0.001
E27.8 Other specified disorders of adrenal gland	0.073	0.926	0.001
E85.8 Other amyloidosis	0.072	0.927	0.001
E74.3 Other disorders of intestinal carbohydrate absorption	0.072	0.927	0.001
W22.5 Trade and service area	0.073	0.927	0.000
E73.9 Lactose intolerance, unspecified	0.068	0.931	0.001
E79 Disorders of purine and pyrimidine metabolism	0.067	0.931	0.002
W22.3 Sports and athletics area	0.068	0.932	0.000
E78.1 Pure hyperglyceridaemia	0.067	0.933	0.000
L43.8 Other lichen planus	0.066	0.934	0.000
E85.3 Secondary systemic amyloidosis	0.065	0.934	0.001
E85.2 Heredofamilial amyloidosis, unspecified	0.065	0.934	0.001
E85.1 Neuropathic heredofamilial amyloidosis	0.065	0.934	0.001
E85.0 Nonneuropathic heredofamilial amyloidosis	0.065	0.934	0.001
E75.5 Other lipid storage disorders	0.065	0.934	0.001
E74.9 Disorder of carbohydrate metabolism, unspecified	0.064	0.935	0.001
E74.8 Other specified disorders of carbohydrate metabolism	0.064	0.935	0.001
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.064	0.935	0.001
E74.2 Disorders of galactose metabolism	0.064	0.935	0.001
E74.1 Disorders of fructose metabolism	0.064	0.935	0.001
W22.2 School, other institution and public administrative area	0.065	0.935	0.000
E21.0 Primary hyperparathyroidism	0.063	0.937	0.000
E73.8 Other lactose intolerance	0.060	0.939	0.001
E73.1 Secondary lactase deficiency	0.060	0.939	0.001
E73.0 Congenital lactase deficiency	0.060	0.939	0.001
W20-W49 Exposure to inanimate mechanical forces	0.061	0.939	0.000
E75.6 Lipid storage disorder, unspecified	0.059	0.940	0.001
E75.4 Neuronal ceroid lipofuscinosis	0.059	0.940	0.001
E75.3 Sphingolipidosis, unspecified	0.059	0.940	0.001
E75.2 Other sphingolipidosis	0.059	0.940	0.001
E75.1 Other gangliosidosis	0.059	0.940	0.001
E75.0 GM2 gangliosidosis	0.059	0.940	0.001
W22.8 Other specified place	0.060	0.940	0.000
W22.6 Industrial and construction area	0.060	0.940	0.000
W22.4 Street and highway	0.060	0.940	0.000
W22.0 Home	0.060	0.940	0.000
W22.7 Farm	0.060	0.940	0.000
W22.1 Residential institution	0.060	0.940	0.000
E78.6 Lipoprotein deficiency	0.060	0.940	0.000
E88.9 Metabolic disorder, unspecified	0.059	0.940	0.001
E84.9 Cystic fibrosis, unspecified	0.058	0.941	0.001
E11.9 Without complications	0.059	0.941	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.058	0.941	0.001
E72.0 Disorders of amino-acid transport	0.057	0.942	0.001
E88.2 Lipomatosis, not elsewhere classified	0.057	0.942	0.001
E83.5 Disorders of calcium metabolism	0.001	0.942	0.057
E85.9 Amyloidosis, unspecified	0.057	0.942	0.001
E84.8 Cystic fibrosis with other manifestations	0.056	0.943	0.001
E84.1 Cystic fibrosis with intestinal manifestations	0.056	0.943	0.001
E84.0 Cystic fibrosis with pulmonary manifestations	0.056	0.943	0.001
E78.3 Hyperchylomicronaemia	0.057	0.943	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.056	0.943	0.001
E72.8 Other specified disorders of amino-acid metabolism	0.056	0.943	0.001
E72.5 Disorders of glycine metabolism	0.056	0.943	0.001
E72.4 Disorders of ornithine metabolism	0.056	0.943	0.001
E72.3 Disorders of lysine and hydroxylysine metabolism	0.056	0.943	0.001
E72.2 Disorders of urea cycle metabolism	0.056	0.943	0.001
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.056	0.943	0.001
E71.3 Disorders of fatty-acid metabolism	0.055	0.944	0.001
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.055	0.944	0.001
E71.1 Other disorders of branched-chain amino-acid metabolism	0.055	0.944	0.001
E71.0 Maple-syrup-urine disease	0.055	0.944	0.001
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.055	0.944	0.001
E76.8 Other disorders of glucosaminoglycan metabolism	0.055	0.944	0.001
E76.3 Mucopolysaccharidosis, unspecified	0.055	0.944	0.001
E76.2 Other mucopolysaccharidoses	0.055	0.944	0.001
E76.1 Mucopolysaccharidosis, type II	0.055	0.944	0.001
E76.0 Mucopolysaccharidosis, type I	0.055	0.944	0.001
E77.9 Disorder of glycoprotein metabolism, unspecified	0.055	0.944	0.001
E77.8 Other disorders of glycoprotein metabolism	0.055	0.944	0.001
E77.1 Defects in glycoprotein degradation	0.055	0.944	0.001
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.055	0.944	0.001
W44 Foreign body entering into or through eye or natural orifice	0.055	0.945	0.000
W21 Striking against or struck by sports equipment	0.055	0.945	0.000
E78.5 Hyperlipidaemia, unspecified	0.055	0.945	0.000
E04 Other non-toxic goitre	0.053	0.946	0.001
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.053	0.946	0.001
E70.8 Other disorders of aromatic amino-acid metabolism	0.053	0.946	0.001
E70.2 Disorders of tyrosine metabolism	0.053	0.946	0.001
E70.1 Other hyperphenylalaninaemias	0.053	0.946	0.001
E70.0 Classical phenylketonuria	0.053	0.946	0.001
W45 Foreign body or object entering through skin	0.053	0.946	0.000
E78.4 Other hyperlipidaemia	0.053	0.947	0.000
E88.8 Other specified metabolic disorders	0.052	0.947	0.001
W44.0 Home	0.052	0.948	0.000
E70.3 Albinism	0.051	0.948	0.001
E78.9 Disorder of lipoprotein metabolism, unspecified	0.051	0.949	0.000
W21.9 Unspecified place	0.051	0.949	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.049	0.950	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.048	0.951	0.001
E79.8 Other disorders of purine and pyrimidine metabolism	0.048	0.951	0.001
E79.1 Lesch-Nyhan syndrome	0.048	0.951	0.001
W49 Exposure to other and unspecified inanimate mechanical forces	0.047	0.953	0.000
W34 Discharge from other and unspecified firearms	0.047	0.953	0.000
W31 Contact with other and unspecified machinery	0.046	0.954	0.000
W45.6 Industrial and construction area	0.046	0.954	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.045	0.955	0.000
W40 Explosion of other materials	0.045	0.955	0.000
W27 Contact with nonpowered hand tool	0.044	0.955	0.000
W46 Contact with hypodermic needle	0.044	0.956	0.000
W43 Exposure to vibration	0.044	0.956	0.000
W42 Exposure to noise	0.044	0.956	0.000
W41 Exposure to high-pressure jet	0.044	0.956	0.000
W39 Discharge of firework	0.044	0.956	0.000
W38 Explosion and rupture of other specified pressurised devices	0.044	0.956	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.044	0.956	0.000
W36 Explosion and rupture of gas cylinder	0.044	0.956	0.000
W35 Explosion and rupture of boiler	0.044	0.956	0.000
W33 Rifle, shotgun and larger firearm discharge	0.044	0.956	0.000
W32 Handgun discharge	0.044	0.956	0.000
W30 Contact with agricultural machinery	0.044	0.956	0.000
W28 Contact with powered lawn mower	0.044	0.956	0.000
W22.09 Striking against or struck by other objects; Home; During unspecified activity	0.043	0.957	0.000
W22.03 Striking against or struck by other objects; Home; While engaged in other types of work	0.043	0.957	0.000
W22.41 Striking against or struck by other objects; Street and highway;While engaged in leisure activity	0.043	0.957	0.000
W22.62 Striking against or struck by other objects; Industrial and construction area ;While working for income	0.043	0.957	0.000
W22.88 Striking against or struck by other objects; Other specified places ;While engaged in other specified activities	0.043	0.957	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.043	0.957	0.000
W26 Contact with knife, sword or dagger	0.043	0.957	0.000
E88.3 Tumour lysis syndrome	0.042	0.957	0.001
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.000	0.958	0.042
W45.8 Other specified place	0.042	0.958	0.000
W45.5 Trade and service area	0.040	0.959	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.039	0.960	0.002
W21.0 Home	0.040	0.960	0.000
W49.9 Unspecified place	0.040	0.960	0.000
W44.9 Unspecified place	0.040	0.960	0.000
W44.5 Trade and service area	0.040	0.960	0.000
W44.7 Farm	0.040	0.960	0.000
W44.6 Industrial and construction area	0.040	0.960	0.000
W44.4 Street and highway	0.040	0.960	0.000
W44.3 Sports and athletics area	0.040	0.960	0.000
W44.2 School, other institution and public administrative area	0.040	0.960	0.000
W44.1 Residential institution	0.040	0.960	0.000
W21.3 Sports and athletics area	0.040	0.960	0.000
W21.8 Other specified place	0.040	0.960	0.000
W21.7 Farm	0.040	0.960	0.000
W21.6 Industrial and construction area	0.040	0.960	0.000
W21.5 Trade and service area	0.040	0.960	0.000
W21.4 Street and highway	0.040	0.960	0.000
W21.2 School, other institution and public administrative area	0.040	0.960	0.000
W21.1 Residential institution	0.040	0.960	0.000
E04.8 Other specified non-toxic goitre	0.038	0.961	0.001
W45.9 Unspecified place	0.038	0.961	0.000
W45.0 Home	0.038	0.961	0.000
W45.7 Farm	0.038	0.961	0.000
W45.4 Street and highway	0.038	0.961	0.000
W45.3 Sports and athletics area	0.038	0.961	0.000
W45.2 School, other institution and public administrative area	0.038	0.961	0.000
W45.1 Residential institution	0.038	0.961	0.000
W44.8 Other specified place	0.037	0.963	0.000
W34.9 Unspecified place	0.036	0.964	0.000
W31.6 Industrial and construction area	0.035	0.965	0.000
E78.8 Other disorders of lipoprotein metabolism	0.035	0.965	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.032	0.965	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations